Cost-effectiveness of Left Ventricular Assist Devices (LVADs) as destination therapy in the UK: An economic modelling study. [PDF]
ObjectivesLeft Ventricular Assist Devices (LVADs) for destination therapy (DT) are used in many countries but in some, like the UK, LVADs are not commissioned due to uncertainty around their cost-effectiveness.
Tuba Saygın Avşar +7 more
doaj +2 more sources
Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach [PDF]
Left Ventricular Assist Device (LVAD) for Destination Therapy (DT) is an established therapy for end stage heart failure patients who are not transplant candidates.
Samuels Louis E +3 more
doaj +2 more sources
Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries [PDF]
Heart transplantation (HT) is the gold standard therapy for advanced heart failure (ADHF), and LVADs as destination therapy are an option in non-HT candidates.
David Dobarro +33 more
doaj +2 more sources
An infectious disease perspective-is destination therapy a viable option for total artificial hearts? [PDF]
Zabner R, Lam LD, Runyan C.
europepmc +3 more sources
Time in Therapeutic Range Significantly Impacts Survival and Adverse Events in Destination Therapy Patients. [PDF]
Macaluso GP +8 more
europepmc +2 more sources
Mechanical circulatory support for destination therapy: why are we so late? [PDF]
Robert Guidoin
doaj +2 more sources
Peritoneal dialysis improves quality-of-life in a left ventricular assist device destination therapy patient-a case report. [PDF]
Koppel CJ +3 more
europepmc +3 more sources
Ventricular assist devices as destination therapy: psychosocial and ethical implications. [PDF]
Grogan S +3 more
europepmc +2 more sources
Impact of mechanical circulatory support on donor heart allocation: past, present, and future [PDF]
The United Network for Organ Sharing (UNOS) recently revised its heart allocation policy to address numerous shortcomings of the previous system. Implemented in 2018, the changes sought to reduce waiting list mortality, clearly define urgency status ...
Robert T. Tatum +2 more
doaj +1 more source
End-of-life decision-making and changing preferences in patients with a left ventricular assist device for destination therapy: insights from advance directives in Japan. [PDF]
Izumida T +11 more
europepmc +3 more sources

